Table 1.
Patient groups
| SAR103168 (mg/m2) | |||||||
|---|---|---|---|---|---|---|---|
| 1.2 | 1.7 | 2.4 | 4.8 | 9.6 | 14.4 | All | |
| Enrolled population | 8 | 4 | 5 | 3 | 5 | 4 | 30 |
| All treated population | 8 | 4 | 5 | 3 | 5 | 4 | 29 |
| DLT assessment population | 6 | 3 | 4 | 3 | 5 | 3 | 24 |
| Pharmacokinetic population | 8 | 4 | 5 | 3 | 5 | 4 | 29 |
| Activity/efficacy population | 8 | 4 | 4 | 3 | 4 | 2 | 25 |